CLA (Conjugated Linoleic Acid) is a family of naturally occurring fatty acids found primarily in the meat and dairy of ruminant animals such as cattle, sheep, and goats. It is a positional and geometric isomer of linoleic acid (a common omega-6 polyunsaturated fat), with the two most studied forms being cis-9, trans-11 (rumenic acid) and trans-10, cis-12. CLA gained attention because early animal research suggested it could reduce body fat through effects on lipid metabolism.

CLA emerged as a popular supplement in the late 1990s after rodent studies showed striking reductions in adipose tissue. Subsequent human trials have produced more modest and mixed effects, with most supplemental products derived from isomerized safflower or sunflower oil rather than from a dietary source. The supplemental isomer profile differs from what is consumed in grass-fed dairy and meat.

This review examines the evidence for and against CLA supplementation in the context of body composition, cardiometabolic markers, and long-term safety, surveying the divergence between animal and human data and where the evidence currently stands for adults pursuing health optimization.

Benefits - Risks - Protocol - Conclusion

Colostrum (also known as bovine colostrum or first milk) is the nutrient-dense fluid produced by mammals in the first hours after birth. Harvested almost exclusively from cows for human supplementation, it contains a rich mix of antibodies, hormone-like signaling molecules, and other active proteins studied for their effects on gut health, immune support, and recovery.

Used historically in Ayurvedic practice and as an early therapeutic agent before the antibiotic era, colostrum re-entered the supplement market in the 1990s as research into intestinal permeability and athletic performance expanded. Trials in athletes, individuals with gastrointestinal symptoms, and older adults have examined whether colostrum’s bioactive compounds survive digestion in sufficient quantities to exert systemic effects — results that remain contested.

This review examines colostrum’s composition, mechanisms of action, the strength of evidence behind its proposed benefits, and the risks and practical considerations involved in its use. It focuses on whether the available data justify the intervention’s place in a longevity-oriented health protocol.

Benefits - Risks - Protocol - Conclusion

Chlorogenic acid (CGA) is a polyphenol found in green coffee beans and smaller amounts in apples, artichokes, blueberries, and yerba mate. It belongs to the hydroxycinnamic acid family of plant antioxidants and acts primarily by modulating glucose absorption and supporting antioxidant defense in the body.

Historically consumed through coffee and tea, chlorogenic acid drew scientific attention when standardized green coffee bean extracts entered the supplement market with claims around weight management, blood sugar regulation, and cardiovascular support. Research interest has since expanded to longevity-relevant pathways such as endothelial function and chronic inflammation, alongside the more established cardiometabolic outcomes.

This review examines the evidence for chlorogenic acid supplementation as a tool for metabolic, cardiovascular, and longevity-oriented support. It evaluates the available human data, the proposed mechanisms, sourcing and dosing considerations, and the risk profile, with a focus on what the evidence does and does not currently support for a population pursuing health optimization.

Benefits - Risks - Protocol - Conclusion

Chitosan is a fiber-like polysaccharide produced by deacetylating chitin, the structural material found in the shells of crustaceans and certain fungi. Because it carries a positive charge in the acidic stomach, it binds negatively charged molecules such as dietary fats and bile acids, a property that has driven its long-standing marketing as a “fat blocker” and lipid-lowering aid.

Beyond weight-related claims, chitosan has been studied across a wide range of applications, from wound dressings and dental biomaterials to cholesterol management and gut-microbiota modulation. Its biocompatibility, biodegradability, and mucoadhesive behavior have made it a workhorse in drug-delivery research, while its use in human nutrition remains more contested.

This review examines what the human evidence shows for orally administered chitosan in adults pursuing health and longevity goals, separating signals that hold up in controlled trials from those that rest mainly on mechanism or marketing. It looks at lipid effects, body-weight outcomes, safety considerations, interactions with other interventions, and the practical issues of sourcing, dosing, and monitoring.

Benefits - Risks - Protocol - Conclusion

Charcoal — most commonly used in its medicinal form as activated charcoal — is a porous form of carbon that binds molecules in the gut through adsorption, preventing their absorption into the body. Interest among health-conscious adults centers on the prospect that this gut-confined binding could reduce the burden of dietary, environmental, and metabolic compounds the body otherwise has to clear, with potential downstream relevance to longevity.

Charcoal has a long history of medicinal use, stretching back thousands of years and central to modern emergency toxicology. More recently it has entered the wellness sphere with broader claims around digestive comfort, “detoxification”, and cosmetic applications such as toothpastes and face masks. Some functional practitioners also use it for gut and toxin-exposure scenarios, while pharmaceutical work has explored refined charcoal-class products in advanced kidney disease.

This review examines the available evidence on charcoal as a longevity-relevant intervention — what it can and cannot do, where the clinical evidence is strong, where it is weak or speculative, and the practical considerations relevant to those evaluating its use.

Benefits - Risks - Protocol - Conclusion

Chamomile (Matricaria chamomilla, German chamomile; Chamaemelum nobile, Roman chamomile) is a daisy-like flowering plant whose dried flower heads have been used as a botanical preparation for over two millennia. It is consumed primarily as a tea or standardized extract and is of interest for its potential effects on sleep, anxiety, and gastrointestinal comfort, with renewed attention to its principal flavonoid, apigenin, in the context of cellular aging.

Historically, chamomile appears in Egyptian, Greek, and Roman medical traditions and remains one of the most consumed herbal infusions globally. Its principal flavonoid apigenin engages inhibitory neurotransmission, providing a plausible mechanistic basis for its traditional uses and contemporary research interest.

This review examines the clinical and mechanistic evidence for chamomile across the outcomes most relevant to a longevity-oriented audience: sleep quality, generalized anxiety, and gastrointestinal function. It also addresses dosing, formulation differences, allergy considerations, sourcing, and how chamomile fits alongside foundational lifestyle inputs.

Benefits - Risks - Protocol - Conclusion

Ceramides are waxy lipid molecules built from a sphingosine backbone bound to a fatty acid. They occur naturally in skin and in plant sources such as wheat, rice, and konjac, and they sit at the center of two distinct conversations in health and longevity. Oral and topical ceramide preparations are positioned as tools for restoring the skin’s barrier as it thins with age, while cardiometabolic research has shown that certain blood-circulating ceramide species predict heart attack, stroke, and insulin resistance.

The skin-barrier role has been studied since the 1980s, and oral phytoceramide products have been sold in Japan and the United States for more than a decade. Large hospital systems now offer commercial blood-ceramide risk panels, and statin and lifestyle trials show these scores can drop substantially with treatment.

This review examines the evidence for exogenous ceramides as a supplement, for topical ceramide formulations, and for treating endogenous blood-ceramide levels as a modifiable longevity marker.

Benefits - Risks - Protocol - Conclusion

CDP-Choline (Citicoline) is a naturally occurring compound the body uses to build phosphatidylcholine, a major component of brain cell membranes, and to produce acetylcholine, a chemical messenger involved in memory and attention. Originally developed as a prescription drug in Europe and Japan for stroke recovery and age-related cognitive decline, it is sold over the counter in the United States as a dietary supplement and is widely used to support focus, memory, and brain aging.

Interest in CDP-Choline within the longevity community has grown alongside research suggesting it may help maintain neuronal membrane integrity and support dopamine signaling. Decades of clinical use abroad have generated a sizable evidence base, though results have been mixed across populations and indications, and the supplement form (often standardized as Cognizin) has been examined separately from the pharmaceutical form.

This review examines the mechanisms, clinical evidence, expected benefits, potential risks, and protocol considerations for CDP-Choline as a long-term cognitive and neurological support agent in adults focused on brain longevity.

Benefits - Risks - Protocol - Conclusion

Casein is the dominant protein in cow’s milk, making up roughly 80% of its protein content. Its defining feature is slow digestion, which delivers amino acids into the bloodstream gradually over several hours. It is consumed both as a natural component of dairy foods and as an isolated supplement, widely used by athletes and older adults seeking to preserve muscle.

Beyond its role as a building block for muscle, casein has accumulated a more contested profile. Different forms behave differently in the body, and small fragments released during digestion have been examined for both potential benefits and potential harms. The conversation around casein has moved past simple muscle support into broader questions about long-term health.

This review examines the evidence for and against casein consumption in the context of health and longevity, with attention to genuine scientific disagreement around muscle preservation, metabolic effects, and tolerance. It draws together the clinical, mechanistic, and observational data, including where strong claims rest on weak evidence.

Benefits - Risks - Protocol - Conclusion

Bakuchi (also called Babchi or Psoralea corylifolia) is a plant native to India and parts of East Asia whose seeds have been used in Ayurvedic and traditional Chinese medicine for centuries to address skin conditions including vitiligo and psoriasis. The plant draws modern interest because one of its compounds, bakuchiol, appears to engage skin-aging pathways in ways that resemble retinoids without sharing their chemical structure or tolerability issues.

Interest in bakuchi for skin rejuvenation surged after a small head-to-head comparison reported that a topical bakuchiol formulation produced improvements in wrinkles and hyperpigmentation comparable to retinol while being better tolerated. This positioned bakuchi-derived ingredients as a possible option for those who cannot use prescription retinoids and for those seeking botanical formulations.

This evidence review examines what is known about topical bakuchi and bakuchiol for skin rejuvenation: the proposed mechanisms, the strength and limitations of the clinical data, distinctions between whole-seed preparations and the purified bakuchiol molecule, plus relevant safety considerations.

Benefits - Risks - Protocol - Conclusion

Arachidonic acid is a long-chain omega-6 polyunsaturated fatty acid found in the membranes of nearly every human cell, particularly in the brain and muscle. It serves as the precursor to signaling molecules that influence inflammation and muscle anabolism. Dietary sources include eggs, poultry, red meat, and certain fish; the body can also synthesize it from linoleic acid.

One view frames arachidonic acid primarily as a driver of chronic inflammation, with corresponding interest in reducing intake. Other evidence highlights essential roles in muscle anabolism and neurodevelopment, alongside questions about whether dietary or supplemental intake meaningfully shifts disease risk in adults. Both framings remain represented in the current literature.

This review examines the evidence on arachidonic acid for health and longevity-oriented adults: where intake or status appears beneficial, where it may carry risk, how it interacts with omega-3 intake, and what the data say about supplementation, dietary loading, and the downstream metabolic balance.

Benefits - Risks - Protocol - Conclusion

Alpha-Lactalbumin (α-Lactalbumin) is a small whey protein found in the milk of nearly all mammals, where it functions as a regulatory subunit in the production of lactose. In humans, it is the most abundant protein in breast milk, but isolated bovine alpha-lactalbumin has emerged as a specialty ingredient pursued for its unusually high tryptophan content, its rich bioactive peptide profile, and its favorable amino acid balance compared with other dietary proteins.

Interest in alpha-lactalbumin as a standalone intervention grew from observations that tryptophan availability strongly influences serotonin signaling, sleep quality, and stress resilience. Researchers have explored whether an evening dose can support mood and sleep by raising the dietary supply of tryptophan reaching the brain, with mixed but ongoing findings across small trials. Separately, oncology research has examined a folded protein-fatty-acid complex derived from the protein for its tumor-selective effects in early-phase clinical settings.

This review examines the body of evidence on isolated alpha-lactalbumin as a nutraceutical, including its effects on sleep, mood, and lean-mass support, the strength and limitations of the underlying mechanistic and clinical data, and the boundaries of what the current human evidence can and cannot reliably support for the target audience.

Benefits - Risks - Protocol - Conclusion

Akkermansia muciniphila (often shortened to Akkermansia) is a mucin-degrading bacterium that lives in the protective mucus layer of the human gut. Although it makes up only a small fraction of the gut microbial community in healthy adults, higher levels track with leaner body weight, better blood-sugar control, and a more robust gut barrier, while lower levels are repeatedly found in obesity, type 2 diabetes, and inflammatory bowel disease.

Identified only in 2004, this bacterium has moved from microbiology curiosity to commercially available oral product within two decades. A pasteurized, non-living form is now sold in Europe as a food supplement, and a heat-killed proprietary strain has received a U.S. food-safety clearance. Early human work suggests effects on metabolism, the intestinal barrier, and immune signaling relevant to long-term health.

This review examines the evidence base for supplementation as a longevity-oriented intervention: what is established in human trials, what remains supported only by mechanistic and animal data, where risks may exist, and how the available product forms differ in quality, dosing, and regulatory standing.

Benefits - Risks - Protocol - Conclusion

Azelaic (azelaic acid) is a naturally occurring nine-carbon dicarboxylic acid found in grains such as wheat, barley, and rye, and produced on healthy skin by certain yeasts. As a topical agent, it acts primarily through modulation of pigment-producing cells and inflammatory signaling in the skin. Interest in it spans both clinical dermatology and cosmetic skincare contexts, where its place relative to other topical agents continues to be examined for tone, texture, and overall skin health.

The compound has been used in dermatology since the 1980s, originally for acne and rosacea, and is now approved as a prescription cream, gel, and foam in many countries. Attention has since extended to pigmentation concerns such as melasma and post-acne dark marks, where it offers an alternative to longer-established lightening agents. Cosmetic-grade formulations have made lower concentrations accessible without prescription, prompting renewed interest in its role within longevity-oriented skincare and routines aimed at long-term skin maintenance.

This review examines the evidence behind topical use of this dicarboxylic acid for skin rejuvenation, focusing on what controlled trials and clinical experience reveal about its benefits, limitations, tolerability, and place alongside other topical agents used for tone and texture.

Benefits - Risks - Protocol - Conclusion

Acetate is a small two-carbon molecule and the active ingredient of vinegar. In the body, it is produced abundantly when gut bacteria ferment dietary fiber, is generated when alcohol is metabolized, and serves as fuel for energy production and a building block for lipids. Interest in acetate as a longevity-relevant molecule has grown alongside the recognition that gut-derived metabolites shape host metabolism, immune tone, and brain function.

Beyond its role as a fuel, acetate also influences appetite, glucose handling, and inflammation through peripheral and central pathways. Vinegar consumption — a centuries-old culinary and folk-medicinal practice — has reentered scientific discussion as a low-cost source of dietary acetate with measurable effects on after-meal blood sugar.

This review examines the evidence base around acetate as a metabolic and longevity-relevant agent, considering effects on glucose regulation, lipid metabolism, body composition, and gut-brain signaling, alongside practical considerations of obtaining it through diet, microbiome support, or supplementation.

Benefits - Risks - Protocol - Conclusion

7,8-Dihydroxyflavone (7,8-DHF, also called tropoflavin) is a small flavone molecule originally isolated from plants such as Godmania aesculifolia and Tridax procumbens. It has drawn attention as a candidate small-molecule activator of the same brain receptor that brain-derived neurotrophic factor uses to support neuronal growth, plasticity, and survival. Because it can cross the blood-brain barrier after oral dosing, it is being explored as a way to engage neurotrophic signaling without injecting a protein, which has long limited therapeutic use of the parent factor.

Interest accelerated after preclinical work in the early 2010s reported pro-cognitive, antidepressant-like, and neuroprotective effects in rodent models of Alzheimer’s disease, stroke, and depression. Independent laboratories have since published both supportive and skeptical findings, including reports questioning whether the compound acts as a direct receptor agonist or through indirect routes. No human clinical trials have been completed, and the compound exists primarily as a research tool and niche dietary ingredient.

This review examines what is currently known about 7,8-dihydroxyflavone for human health and longevity: its proposed mechanisms, the preclinical evidence base, the unresolved debate over target identification, and the substantial uncertainty that remains around dosing, durability, and long-term safety in the absence of human data.

Benefits - Risks - Protocol - Conclusion

Zinc is an essential trace mineral required by hundreds of enzymes and thousands of regulatory proteins. It plays structural and catalytic roles across many cellular processes, with immune function and growth among its most prominent. Because the body has no dedicated long-term store for zinc, intake must continuously meet demand, and even modest deficits can affect immunity and skin health.

Zinc has been studied for over half a century, with notable interest tracing back to the recognition of zinc-deficiency syndromes in the Middle East in the 1960s. Attention has since broadened to age-related immune decline, oxidative stress, and metabolic regulation — areas where deficiency is common in older adults but where excess intake also carries identifiable harms, particularly through interference with copper status.

This review examines the evidence on zinc as a longevity-relevant intervention, including conditions under which supplementation is supported by clinical data, populations most likely to benefit, appropriate forms and doses, and the trade-offs and ceilings that apply at higher intakes.

Benefits - Risks - Protocol - Conclusion

Wellmune is a purified, proprietary form of beta 1,3/1,6-glucan (Yeast Beta-Glucan) derived from baker’s yeast and marketed as an immune-support ingredient in supplements, functional foods, and beverages. It primes innate immune cells — neutrophils and macrophages — to respond more efficiently to infectious or environmental challenges, without broadly stimulating inflammation.

The ingredient has been studied in dozens of human trials over the past two decades, with much of the research funded by the manufacturer. It has gained interest among health- and longevity-oriented adults seeking support against upper respiratory infections, training-induced immune suppression, and age-related decline of innate immune surveillance. Cereal beta-glucans from oats and barley target cholesterol and blood sugar through different mechanisms and are not interchangeable with the yeast-derived form.

This review examines the available evidence on Wellmune across its main proposed benefits, side effects, dosing protocols, sourcing quality, and how it interacts with foundational health habits such as sleep, nutrition, exercise, and stress management.

Benefits - Risks - Protocol - Conclusion

Uridine is a naturally occurring nucleoside found in human breast milk, beer, and certain organ meats. Inside the body it serves as a building block for the fatty molecules that make up brain cell membranes and the connections between brain cells. Interest in supplemental uridine has grown among those targeting cognitive performance, mood support, and brain aging, where it is often paired with omega-3 fatty acids and choline.

Originally studied as a chemoprotective rescue agent for fluorouracil toxicity, uridine entered the longevity conversation through animal work showing increased synaptic density and dendritic spine formation, followed by human trials in mood disorders and Alzheimer’s-related cognitive decline using a multinutrient medical food. The supplement community has since adopted uridine monophosphate at much lower doses for daily use, despite a thinner human evidence base outside of disease populations.

This review examines what is currently known about uridine’s biology, the strength of the evidence for cognitive, mood, and longevity-relevant outcomes, the practical considerations of supplementation, and the open questions that limit firmer conclusions.

Benefits - Risks - Protocol - Conclusion

Cardio training, also called aerobic exercise, refers to sustained rhythmic activity using large muscle groups — walking, running, cycling, swimming, rowing — at intensities that elevate heart rate and breathing for extended periods. The body adapts by strengthening the heart and raising the rate at which muscles can use oxygen.

Since mid-20th-century studies linked occupational activity to lower coronary mortality, public health bodies have framed sustained aerobic activity as a primary preventive intervention; competing positions argue for brief high-intensity intervals, others for resistance work, and a contrarian strand questions whether population-level guidelines are well-calibrated for proactive individuals. Modern frameworks separate the work into lower-intensity steady-state efforts and brief high-intensity intervals, with debate continuing over the optimal blend and where benefits plateau or reverse at higher exposures.

This review examines the evidence for cardio training as a longevity intervention: what fitness gains translate to in years of healthspan, where dose-response relationships plateau, which protocols leading practitioners favor, and what risks accompany sustained or extreme training volumes over decades.

Benefits - Risks - Protocol - Conclusion

Female Hormone Replacement Therapy (HRT) is the medical replacement of ovarian hormones — primarily estrogen, often paired with progestogen and sometimes testosterone — that decline during menopause. It emerged to relieve hot flashes and night sweats, and has since been studied for bone and cardiovascular outcomes that change rapidly as endogenous estrogen falls.

Women spend roughly a third of life in a low-estrogen state, and the years surrounding the final menstrual period are marked by accelerated bone loss, vascular stiffening, and shifts in body composition. A landmark trial reframed prescribing in the early 2000s, but later re-analyses by age and time since menopause have produced a more nuanced picture, with active debate about long-term benefits and risks.

This review examines what is known about hormone replacement applied with longevity intent: the mechanisms by which it acts, the strength of evidence for each claimed benefit and risk, the protocols used by leading practitioners, and the monitoring approach that allows early identification of both response and harm.

Benefits - Risks - Protocol - Conclusion

Male hormone replacement therapy (Male HRT) refers to the medical administration of exogenous testosterone — and sometimes adjunct hormones used to preserve fertility and manage estrogen — to men whose endogenous testosterone production has declined. Testosterone is the principal male androgen, governing body composition, sexual function, and metabolic regulation. Levels typically peak in the second decade of life and decline gradually thereafter, with measurable consequences for vitality and quality of life in a meaningful subset of aging men.

Interest in Male HRT has grown alongside rising rates of obesity, metabolic syndrome, and reported low-testosterone symptoms, along with broader cultural attention to men’s healthspan. The therapy sits at the intersection of mainstream medicine and longevity practice, with conventional guidelines applying narrow eligibility criteria centered on specific lab cutoff values, while integrative and longevity-oriented clinicians advocate broader use guided by symptom burden and a wider read of testosterone-related lab values. Recent large randomized cardiovascular safety data have reshaped the safety conversation.

This review examines the evidence for and against Male HRT as a tool for healthspan extension, including its established benefits, residual safety questions, optimal monitoring, and where conventional and longevity-oriented practitioners diverge.

Benefits - Risks - Protocol - Conclusion

Tongkat Ali (Eurycoma longifolia) is a flowering shrub native to Southeast Asia whose root has a long traditional history as a tonic for male vitality, fatigue, and libido. Standardized extracts of the root contain plant compounds proposed to support the body’s natural testosterone production.

Interest in the herb intensified after small clinical trials in middle-aged and older men reported increases in testosterone, improvements in symptoms of low male hormone levels, and reductions in stress hormone. Standardized extracts have become some of the most-studied botanical candidates in the male-vitality category, and the herb is widely used by individuals seeking a non-prescription option to support male hormone status.

This review examines the evidence for Tongkat Ali as an intervention to improve testosterone status, including the magnitude and consistency of hormonal changes, downstream effects on body composition and well-being, the quality of the supporting trials, sourcing concerns, and the safety profile relevant to longevity-oriented adults.

Benefits - Risks - Protocol - Conclusion

Tazarotene is a synthetic, third-generation topical retinoid originally approved in the late 1990s for psoriasis and acne, and later approved by regulators specifically for the cosmetic improvement of facial photodamage. Within the broader retinoid family, it stands apart from tretinoin and adapalene because it binds selectively to a specific subset of nuclear receptors that control how skin cells grow, mature, and shed.

Interest in tazarotene for skin rejuvenation grew when controlled trials demonstrated measurable improvements in fine lines, mottled hyperpigmentation, and skin roughness within a few months of nightly use. It has since become one of only two topical retinoids with regulatory approval explicitly framed around photoaging, alongside tretinoin.

This review examines the evidence for using tazarotene to improve the visible signs of skin aging — including fine wrinkles, uneven pigmentation, and texture irregularities — along with its mechanism, comparative potency relative to other retinoids, tolerability profile, and the protocols used by dermatologists experienced with retinoid therapy.

Benefits - Risks - Protocol - Conclusion

Squalene is a natural lipid produced by the human body and found abundantly in the skin’s surface oils, where it helps maintain the protective barrier and locks in moisture. Production peaks in the late teens and declines with age, contributing to dryness, reduced elasticity, and loss of suppleness. Topical application of squalene, or its shelf-stable hydrogenated form squalane, has become a widely used strategy for restoring this lost lipid and supporting skin rejuvenation.

Once sourced almost exclusively from deep-sea shark liver oil, squalene is now produced from olives, sugarcane, amaranth, and rice bran, broadening accessibility and reducing ecological concerns. Interest in the molecule extends to its roles as a surface antioxidant and as a vehicle for delivering other actives. The global skincare market has rapidly absorbed squalane into serums, oils, and creams marketed for dryness, fine lines, and barrier repair.

This review examines the evidence on topical squalene and squalane for skin rejuvenation, including the mechanisms by which they act on the cutaneous barrier, the strength of the available data, the potential risks and limitations, and how application fits within a broader skin-health protocol.

Benefits - Risks - Protocol - Conclusion